Use of avacopan in severe forms of ANCA-associated vasculitis. Comment on \"Inhibiting C5a/C5aR to treat ANCA-associated vasculitides‿ by Terrier et al. Joint Bone Spine 2023;90:105472. - Université de Lille Accéder directement au contenu
Article Dans Une Revue Joint Bone Spine Année : 2023

Use of avacopan in severe forms of ANCA-associated vasculitis. Comment on \"Inhibiting C5a/C5aR to treat ANCA-associated vasculitides‿ by Terrier et al. Joint Bone Spine 2023;90:105472.

Fichier non déposé

Dates et versions

hal-04490785 , version 1 (05-03-2024)

Identifiants

Citer

Quentin Astouati, François Provot, Meryem-Maud Farhat, David Launay, Sébastien Sanges. Use of avacopan in severe forms of ANCA-associated vasculitis. Comment on \"Inhibiting C5a/C5aR to treat ANCA-associated vasculitides‿ by Terrier et al. Joint Bone Spine 2023;90:105472.. Joint Bone Spine, 2023, Joint Bone Spine, pp.105522. ⟨10.1016/j.jbspin.2023.105522⟩. ⟨hal-04490785⟩

Collections

RIIP UNIV-LILLE
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More